CX Institutional’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.47M | Buy |
|
|||||
|
2025
Q2 | $7.03M | Buy |
|
|||||
|
2025
Q1 | $7.74M | Sell |
|
|||||
|
2024
Q4 | $7.65M | Buy |
|
|||||
|
2024
Q3 | $6.83M | Buy |
|
|||||
|
2024
Q2 | $3.03M | Buy |
|
|||||
|
2024
Q1 | $3.42M | Sell |
|
|||||
|
2023
Q4 | $4.54M | Buy |
|
|||||
|
2023
Q3 | $3.47M | Sell |
|
|||||
|
2023
Q2 | $6.53M | Buy |
|
|||||
|
2023
Q1 | $6.85M | Buy |
|
|||||
|
2022
Q4 | $1.16M | Buy |
|
|||||
|
2022
Q3 | $996K | Sell |
|
|||||
|
2022
Q2 | $1.69M | Sell |
|
|||||
|
2022
Q1 | $3.37M | Buy |
|
|||||
|
2021
Q4 | $314K | Sell |
|
|||||
|
2021
Q3 | $427K | Sell |
|
|||||
|
2021
Q2 | $527K | Buy |
|
|||||
|
2021
Q1 | $411K | Buy |
|
|||||
|
2020
Q4 | $374K | Buy |
|
|||||
|
2020
Q3 | $301K | Buy |
|
|||||
|
2020
Q2 | $237K | Buy |
|
|||||
|
2020
Q1 | $228K | Sell |
|
|||||
|
2019
Q4 | $273K | Buy |
|
|||||
|
2019
Q3 | $196K | Sell |
|
|||||
|
2019
Q2 | $178K | Sell |
|
|||||
|
2019
Q1 | $221K | Buy |
|
|||||
|
2018
Q4 | $229K | Buy |
|
|||||
|
2018
Q3 | $74K | Hold |
|
|||||
|
2018
Q2 | $66K | Buy |
|